Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae , and Blomia tropicalis.

World Allergy Organ J · 2022 · PMC9467880 · PMID 36119655

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

Comparative statistics (Friedman test) indicated that the differences between the groups are highly significant (P < 0.0001) ( Fig. 1 C) even after only the first 3 months of treatment with Alxoid.

also in 132,142 other papers

a clear trendno p-value reported

There is a clear trend towards less consumption of medication for asthma control.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of <i>Dermatophagoides pteronyssinus, Dermatophagoides farinae</i> <i>,</i> and <i>Blomia tropicalis</i>.

The sentences